Cyberknife Treatment Deliver System equipped with the Xchange Robotic Collimator Changer; Linear ...

FDA Device Recall #Z-2640-2026 - Class II, June 16, 2026

Recall Summary

Recall Number Z-2640-2026
Classification Class II - Moderate risk
Date Initiated June 16, 2026
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Accuray Incorporated
Location Madison, WI
Product Type Devices
Quantity 48 units

Product Description

Cyberknife Treatment Deliver System equipped with the Xchange Robotic Collimator Changer; Linear Accelerator

Reason for Recall

In certain cases, a collimator may not fully dock, which triggers a system interlock and prevents motion from the operator console. If personnel then enter the treatment room and initiate motion using the in-room control pendant, the collimator may release and fall from the housing.

Distribution Pattern

Worldwide distribution - US Nationwide and the countries of China, Colombia, Czech Republic, France, Hong Kong, Japan, Korea, Republic of, Latvia, Mexico, Myanmar, Saudi Arabia, Taiwan, Turkey, Ukraine.

Lot / Code Information

All systems prior with software version 11X that utilize the Exchange Table

Other Recalls from Accuray Incorporated

Recall # Classification Product Date
Z-2644-2026 Class II Cyberknife Treatment Deliver System equipped wi... Jun 16, 2026
Z-1023-2025 Class II CyberKnife Treatment Delivery System, REF 06600... Dec 23, 2024
Z-2489-2023 Class II Upper roller bracket (part number 1088370) for ... Aug 3, 2023
Z-1272-2021 Class II CyberKnife Treatment Delivery System - Product ... Feb 26, 2021
Z-0785-2021 Class II TomoTherapy Treatment Delivery System with iDMS... Dec 10, 2020

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic, removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency, Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.